•  
  •  
 

Central Asian Journal of Medicine

Abstract

Systemic lupus erythematosus (SLE) is an autoimmune systemic inflammatory disease with a variety of clinical manifestations. Gout is a systemic tophi disease characterized by the deposition of crystals of sodium monourate in various tissues and developing in connection with this inflammation in persons with hyperuricemia (HU) caused by environmental and / or genetic factors. Currently, the number of young patients is growing steadily with an increase in the number of patients with gout among women. The combination of SLE and gout is rare, and there are very few descriptions of such clinical situations. The article contains literature data concerning the combination of systemic lupus erythematosus (SLE) and gout. Peculiarities of pathogenetic mechanisms and therapeutic tactics in combination of two nosological forms are discussed. Based on the analysis of literature data, the article analyzes the features of the onset and clinical picture of SLE against the background of gout, discusses aspects of diagnosis verification, taking into account the need for early prescription of effective therapy and improvement of prognosis. The paper presents our own clinical observation of a combination of SLE and gouty arthritis in a young patient.

First Page

47

Last Page

55

References

1. Amirov NB Violations of purine metabolism, hyperuricemia, gout and their complications in general clinical practice (clinic, diagnostics, treatment, prevention) / ed. N. B. Amirova. - Kazan: Medicine, 2010.-44 p. 2. Arutyunov GP Tubulointerstitial apparatus of the kidney and its lesion in arterial hypertension // Clinical nephrology. 2011. - No. 1. - S. 52-57. 3. Atakhanova L. E., Tsurko V. V., Buleeva I. M. and others. Gout: from etiology and pathogenesis to diagnosis and rational pharmacotherapy // Modern rheumatology. 2007. - No. 2. - C 13 - 18. 4. Vasilkova TN, Mataev SI, Popova TN et al. Metabolic syndrome: the impact of impaired purine metabolism on its main components // Bulletin of the SB RAMS. 2009. - No. 1 (135). -FROM. 38-41. 5. Eliseev MS, Barskova VG. Disorders of carbohydrate metabolism in gout: detection rate and clinical features // Therapeutic archive. 2013; 82 (5): 50–4.1. 6. Enko BO, Luzikova Ya. S., Maiboroda AA and others. The reasons for the development and features of the course of gout // Young scientist. - 2018. - No. 15 (201). -FROM. 145-148. - URL: https://moluch.ru/archive/201/49392/ 7. Clinical immunology and allergology / Under genus. L. Yeager: Per. with him. - M., 1986. - T. 1. - S. 302 - 370. 8. Mechanisms of immunopathology / Ed. S. Coen and others: Per. from English - M., 1983. - S. 345-360. 9. Muravyov Yu. V., Alekseeva AV, Muravyova NV Gout in young women induced by furosemide // Scientific and practical rheumatology. - 2011. - No. 47. - P. 75–7. 10. Nasonov EL, Soloviev SK. Prospects for pharmacotherapy of systemic lupus erythematosus // Scientific and practical rheumatology. 2014; 52 (3): 311-21. 11. Bertolli A.M., Alarcon G.S., Calvo-Alen J.et al. Systemic lupus erythematosus in a multiethnic US cohort. Clinical features, course and outcome in patients with late-onset disease // Arthr Rheum 2016;54(5):1580–7. 12. Global epidemiology of gout: prevalence, incidence and risk factors // www.nature.com. URL: https://www.nature.com/articles/nrrheum.2015.91. 13. Kanbay M., Solak Y., Dogan E. and all. Uric acid in hypertension and renal disease: The chicken or the egg? // Blood Purif. 2010. - N 30. - P. 288-295. 14. Martin N. E., Nieto V. G. Hypouricemia and tubular transport of uric acid // Nefrologia. 2011. - V. 31, N 1. - P. 44 - 50. 15. Mazzalia M., Kazamel R., Johnson R. J. Could uric acid have a pathogenic role in chronic allograft dysfunction? // Arab Journal of Nephrology and Transplantation. 2009. - Sep 2. - N 3. - P. 37 - 41. 16. Urowitz M.B., Gladman D.D. How to improve morbidity and mortality in systemic lupus erythematosus // Rheumatology, 2010, 39, 238-44. 17. van Vollenhoven RF, Mosca M, Bertsias G, et al., Treat-to-target in systemic lupus erythematosus: recommendations from an international task force // Ann Rheum Dis. 2014 Jun;73(6):958-67. 18. Weening JJ, D’Agati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited // J Am Soc Nephrol. 2004; 15(2): 241-50.

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.